NCT00108667View on ClinicalTrials.gov

Talampanel to Treat Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

February 28, 2006

Conditions
Parkinson Disease
Interventions
DRUG

IV Levodopa

DRUG

Talampanel

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00108667 - Talampanel to Treat Parkinson's Disease | Biotech Hunter | Biotech Hunter